Pinnacle Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,368
| Closed | -$94.6K | – | 252 |
|
|
2026
Q1 | $94.6K | Sell |
3,368
-1,561
| -32% | -$41.6K | 0.03% | 173 |
|
|
2025
Q4 | $123K | Buy |
+4,929
| New | +$124K | 0.04% | 168 |
|
|
2024
Q4 | – | Sell |
-6,009
| Closed | -$174K | – | 252 |
|
|
2024
Q3 | $174K | Sell |
6,009
-498
| -8% | -$14.5K | 0.07% | 159 |
|
|
2024
Q2 | $182K | Hold |
6,507
| – | – | 0.07% | 158 |
|
|
2024
Q1 | $181K | Sell |
6,507
-205
| -3% | -$5.69K | 0.07% | 158 |
|
|
2023
Q4 | $193K | Buy |
6,712
+1,300
| +24% | +$39.3K | 0.08% | 160 |
|
|
2023
Q3 | $180K | Sell |
5,412
-325
| -6% | -$11.5K | 0.08% | 153 |
|
|
2023
Q2 | $210K | Buy |
5,737
+500
| +10% | +$19.5K | 0.09% | 145 |
|
|
2023
Q1 | $214K | Sell |
5,237
-230
| -4% | -$9.93K | 0.1% | 146 |
|
|
2022
Q4 | $280K | Buy |
5,467
+300
| +6% | +$14.4K | 0.13% | 145 |
|
|
2022
Q3 | $226K | Hold |
5,167
| – | – | 0.11% | 144 |
|
|
2022
Q2 | $271K | Hold |
5,167
| – | – | 0.12% | 143 |
|
|
2022
Q1 | $267K | Sell |
5,167
-289
| -5% | -$15K | 0.11% | 151 |
|
|
2021
Q4 | $322K | Sell |
5,456
-125
| -2% | -$6.19K | 0.14% | 146 |
|
|
2021
Q3 | $240K | Sell |
5,581
-307
| -5% | -$13.6K | 0.11% | 147 |
|
|
2021
Q2 | $231K | Buy |
5,888
+554
| +10% | +$21.5K | 0.11% | 139 |
|
|
2021
Q1 | $193K | Hold |
5,334
| – | – | 0.09% | 150 |
|
|
2020
Q4 | $196K | Sell |
5,334
-447
| -8% | -$16.4K | 0.1% | 149 |
|
|
2020
Q3 | $201K | Sell |
5,781
-22,855
| -80% | -$801K | 0.12% | 146 |
|
|
2020
Q2 | $888K | Sell |
28,636
-2
| -0% | -$68 | 0.42% | 83 |
|
|
2020
Q1 | $887K | Buy |
28,638
+1,318
| +5% | +$44.9K | 0.51% | 62 |
|
|
2019
Q4 | $1.02M | Sell |
27,320
-22
| -0.1% | -$784 | 0.38% | 97 |
|
|
2019
Q3 | $932K | Buy |
27,342
+2,549
| +10% | +$92.7K | 0.35% | 104 |
|
|
2019
Q2 | $1.02M | Buy |
24,793
+95
| +0.4% | +$3.77K | 0.38% | 94 |
|
|
2019
Q1 | $995K | Sell |
24,698
-54
| -0.2% | -$2.16K | 0.37% | 98 |
|
|
2018
Q4 | $1.03M | Sell |
24,752
-231
| -0.9% | -$9.59K | 0.42% | 91 |
|
|
2018
Q3 | $1.04M | Sell |
24,983
-58
| -0.2% | -$2.23K | 0.36% | 102 |
|
|
2018
Q2 | $862K | Sell |
25,041
-216
| -0.9% | -$7.38K | 0.3% | 116 |
|
|
2018
Q1 | $850K | Buy |
25,257
+1,720
| +7% | +$59.1K | 0.32% | 111 |
|
|
2017
Q4 | $809K | Buy |
23,537
+44
| +0.2% | +$1.5K | 0.29% | 118 |
|
|
2017
Q3 | $796K | Buy |
23,493
+1,207
| +5% | +$38.8K | 0.29% | 120 |
|
|
2017
Q2 | $710K | Buy |
22,286
+1,563
| +8% | +$49.3K | 0.28% | 117 |
|
|
2017
Q1 | $673K | Sell |
20,723
-102
| -0.5% | -$3.22K | 0.26% | 121 |
|
|
2016
Q4 | $642K | Sell |
20,825
-1,021
| -5% | -$31.2K | 0.25% | 128 |
|
|
2016
Q3 | $702K | Sell |
21,846
-127
| -0.6% | -$4.25K | 0.28% | 118 |
|
|
2016
Q2 | $734K | Sell |
21,973
-44
| -0.2% | -$1.4K | 0.31% | 116 |
|
|
2016
Q1 | $619K | Sell |
22,017
-1,654
| -7% | -$47.2K | 0.3% | 115 |
|
|
2015
Q4 | $725K | Sell |
23,671
-218
| -0.9% | -$6.86K | 0.34% | 102 |
|
|
2015
Q3 | $712K | Buy |
23,889
+174
| +0.7% | +$5.58K | 0.31% | 105 |
|
|
2015
Q2 | $754K | Sell |
23,715
-401
| -2% | -$13.1K | 0.28% | 105 |
|
|
2015
Q1 | $796K | Sell |
24,116
-1,540
| -6% | -$49K | 0.29% | 102 |
|
|
2014
Q4 | $758K | Sell |
25,656
-1,040
| -4% | -$29.8K | 0.25% | 108 |
|
|
2014
Q3 | $749K | Buy |
26,696
+2,789
| +12% | +$78.3K | 0.19% | 114 |
|
|
2014
Q2 | $673K | Sell |
23,907
-897
| -4% | -$25.6K | 0.16% | 119 |
|
|
2014
Q1 | $756K | Buy |
24,804
+2,337
| +10% | +$69.7K | 0.21% | 109 |
|
|
2013
Q4 | $653K | Sell |
22,467
-1,308
| -6% | -$38.1K | 0.19% | 104 |
|
|
2013
Q3 | $648K | Sell |
23,775
-1,031
| -4% | -$28.1K | 0.21% | 104 |
|
|
2013
Q2 | $659K | Buy |
+24,806
| New | +$685K | 0.21% | 102 |
|
Other funds holding PFE
Pinnacle Holdings's PFE Position: Q2 2026 in Review
Pinnacle Holdings sold out of Pfizer (PFE) in Q2 2026, closing a stake of 3,368 shares — an estimated $94.6K sold.
Pinnacle Holdings first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $1.04M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pinnacle Holdings reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Pinnacle Holdings sold 3,368 Pfizer shares in Q2 2026, an estimated $94.6K.
- Pinnacle Holdings first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
- Pinnacle Holdings's Pfizer position peaked at $1.04M in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pinnacle Holdings's 13F filing for Q2 2026, filed 12 Aug 2026.